Rare genitourinary neoplasms encompass diseases of the kidney, bladder, prostate, and penile tract that are of uncommon histology. These entities often pose a major diagnostic and treatment dilemma to the treating physician.
Evidence from multiple positive trials, support from literature reviews and editorials, and the endorsements of professional societies and funding agencies all promote the use of patient-reported outcomes (PROs) in clinical cancer care.
Cannabis use in Western medicine was initially popularized by Irish physician William B. O’Shaughnessy in 1840. It was included in the U.S. Pharmacopeia shortly afterward and was often prescribed for rheumatism, cholera, tetanus, rabies, and labor pain.
Enrique Soto, MD, of the Salvador Zubiran National Institute of Medical Science and Nutrition, in Mexico City, grew up to the sound of seismic alarms. Mexico City is located on a fault line, and Dr. Soto was no stranger to feeling the earth shake beneath his feet.
Lori J. Pierce, MD, FASCO, a professor of radiation oncology at the University of Michigan School of Medicine and the University’s Vice Provost for Academic and Faculty Affairs, is this year’s recipient of the Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award.
Beyond its practice-changing science and networking opportunities, it’s hard to deny that a big draw of attending the ASCO Annual Meeting is the chance to travel to Chicago, one of the country’s most historically significant and culturally rich cities.
In 2014, Chicago began development of McCormick Square, the area directly adjacent to McCormick Place—America’s largest convention center and host of the ASCO Annual Meeting—and attendees this year will see big changes to the neighborhood as a result.
The ASCO Annual Meeting brings together more than 32,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. Read on for resources and tips that will help simplify your experience.